A safe and effective method to implant a totally implantable access port in patients with synchronous bilateral mastectomies: modified femoral vein approach

J Surg Oncol. 2008 Sep 1;98(3):197-9. doi: 10.1002/jso.21048.

Abstract

Background: The purpose of this study was to develop a modified method to implant a totally implantable access port (TIAP) using the femoral vein approach.

Methods: We designed a modified method using the femoral vein approach to implant a TIAP in patients with synchronous bilateral breast cancer requiring bilateral mastectomy and postoperative chemotherapy. TIAP implantation was performed with parenteral sedation and local anesthesia in the operating room. All patients were followed for at least 12 months and the complications of TIAP were recorded.

Results: In this retrospective study, 86 patients received the TIAP using the modified femoral vein approach. All patients had a history of bilateral breast cancer and underwent bilateral mastectomy. The early complication rate within the first 30 postoperative days was 2.3% and involved groin hematoma caused by missed puncture to the femoral artery during the operation. The late postoperative complication rates were 2.3% caused by local port infection, 1.2% by groin wound infection, and 3.5% by catheter occlusion. There were no complications associated with TIAP disconnection or systemic infection.

Conclusion: Traditional implantation of TIAP through the subclavian vein or cephalic vein is simple and is used worldwide. However, both the percutaneous puncture and cutdown methods have limitations and risks. We describe a safe and effective method using the modified femoral vein approach for specific patients.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / administration & dosage
  • Breast Neoplasms / complications
  • Breast Neoplasms / radiotherapy
  • Breast Neoplasms / surgery*
  • Catheterization, Central Venous*
  • Catheters, Indwelling
  • Female
  • Femoral Vein*
  • Humans
  • Mastectomy*
  • Middle Aged
  • Postoperative Complications
  • Retrospective Studies

Substances

  • Antineoplastic Agents